FDA Investigator Nabil Nakhoul

Nabil Nakhoul has conducted inspections on 108 sites in 5 countries as of 04 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
108
Last Inspection Date:
04 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
100009245
Countries of Inspections:
United States of America, Dominican Republic, Canada, Denmark, United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with Nabil Nakhoul:
Abby E Pelletier, Adaliz Santaliz Cruz, Akbar J Zaidi, Alan M Stevens, Alice C Silva, Allison A Rodriguez, Althea A Williams, Amber G Wardwell, Amy C Jordan, Andre S Lamontagne, Andrew M Barlow, Anthony C Warchut, Brenda P King, Burnell M Henry, Camerson E Moore, Carla C Tuite, Catherine J Laufmann, Charisse K Green, Cheryl D Mccall, Christian D Lynch (CDL), Christopher K Vantwuyver, Constance Desimone, Courtney N Long, Darin S Wiegers, Daryl A Dewoskin, David C Sullivan, David J Feria, David P Vanhouten, Dawn M Braswell, Dennis R Hock, Diane M Biron, Dolores Harper, Dominic R Frasca, Dorothy W Lee, Elizabeth B Griffin, Emir Galevi, Fouad Attioui, Garry H Stewart, Gary J Hagan, George T Allen, Jr, Goushi Kubota, Guozhou Mo, Holly S Simms, Hugh M Mcclure, II, James H Tanner, James P Finn, James W Whitney, Jason A Rossi, Jason B Prosser, Jeffrey J Thibodeau, Joann F Fujikawa, John A Hamilton, III, John A Sciacchitano, Jonathan B Lewis, Jonathan G Matrisciano, Joshua D Levin, Justine M Corson, Kalkidan A Molla, Karen Mcnabb Noon, Kayla R Huffman, Kelvin Cheung, Kent A Conforti, Kristina J Donohue, Lauren M Lawrance, Lauren M Mclaughlin, Laurie B Frazier, LCDR Debra Emerson, Lisa D Cash, Lisa M Ayer, Margaret E Walsh, Mark A Heard, Mark R Mcclain, Martin J Guardia, Mary Jeanet Mcgarry, Maryam Tabatabaie, Matthew C Watson, Matthew D Silverman, Maura Rooney, Megan A Haggerty, Michael P Sweeney, Michelle M Noe Varga, Monica Cburgos Garcia, Nadia R Barreda, Nassim Ben Makhlouf, Omotunde O Osunsanmi, Paul A Bonneau, Paul P Geraci, Philip H Lafleur, Philip Kreiter, Phillip E Mclaughlin, Prabhu P Raju, Robert J Martin, Robert Jennings, Ryan J Mcgowan, Sandra P White, Sara M Onyango, Sara M Richardson, Seth A Mailhot, Stacey S Degarmo, Stephen C Smith, Stephen D Brown, Sunita Pandey, Suzanne M Healy, Tamara S Rosbury, Terry C Kimball, Victoria M Daddeo, Wendy R Blame, William K Dagley, Yumi J Hiramine

Nabil Nakhoul's Documents

Publish Date Document Type Title
September, 2021 FDA 483 T2 Biosystems, Inc. - Form 483, 2021-09-24
April, 2016 FDA 483 W & R Investments LLC d.b.a. Laser Engineering - Form 483, 2016-04-15
March, 2019 FDA 483 Triumvirate Environmental, Inc. - Form 483, 2019-03-18
November, 2016 FDA 483 Diabetic Dabs Inc. - Form 483, 2016-11-15
August, 2016 FDA 483 The Helping Hand Company Alliance LLC - Form 483, 2016-08-31
November, 2021 FDA 483 AmericanBio Inc. - Form 483, 2021-11-04
May, 2023 FDA 483 TEI Biosciences, Inc. - Form 483, 2023-05-17
July, 2016 FDA 483 Louis M. Gerson Co., Inc. - Form 483, 2016-07-26
April, 2022 FDA 483 Med Pen Concepts, LLC - Form 483, 2022-04-13
April, 2024 FDA 483 OBP Surgical Corporation - Form 483, 2024-04-10
October, 2019 FDA 483 LaunchWorks LLC - Form 483, 2019-10-23
August, 2023 FDA 483 InfuTronix LLC - Form 483, 2023-09-07
December, 2019 FDA 483 Umano Medical, Inc. - Form 483, 2019-12-04
March, 2017 FDA 483 Mevion Medical Systems, Inc. - Form 483, 2017-03-30
January, 2023 FDA 483 Candela Corporation - Form 483, 2023-01-24
June, 2022 FDA 483 LeMaitre Vascular, Inc. - Form 483, 2022-06-15
December, 2018 FDA 483 Philips North America, LLC - Form 483, 2018-12-04
September, 2018 FDA 483 Valeritas, Incorporated - Form 483, 2018-09-20
April, 2019 FDA 483 United Service Solutions, LLC - Form 483, 2019-04-12
February, 2022 FDA 483 New England Ortho Laboratory, Inc. - Form 483, 2022-02-18
August, 2016 FDA 483 Zyno Medical LLC - Form 483, 2016-08-11
December, 2016 FDA 483 Suture Concepts - Form 483, 2016-12-08
October, 2019 FDA 483 MicroVision, Inc. - Form 483, 2019-10-03
January, 2019 FDA 483 SpineFrontier, Inc. - Form 483, 2019-01-29
May, 2018 FDA 483 Saphena Medical, Inc. - Form 483, 2018-05-24
January, 2018 FDA 483 Medtronic Navigation, Inc.-Boxborough - Form 483, 2018-01-03
July, 2019 FDA 483 DERMAL PHOTONICS CORPORATION - Form 483, 2019-07-24
September, 2017 FDA 483 Terumo Cardiovascular Systems Corp - Form 483, 2017-09-25
October, 2021 FDA 483 Associates of Cape Cod, Inc. - Form 483, 2021-10-21
August, 2022 FDA 483 CardioFocus, Inc. - Form 483, 2022-08-11
March, 2017 FDA 483 Ives EEG Solutions, LLC - Form 483, 2017-03-23
October, 2022 FDA 483 W & R Investments LLC d.b.a. Laser Engineering - Form 483, 2022-10-13
July, 2016 FDA 483 VisionAid, Inc. - Form 483, 2016-07-12
May, 2023 FDA 483 Response TEI Biosciences, Inc. - Form 483R, 2023-05-17
October, 2016 FDA 483 Corindus Inc - Form 483, 2016-10-04
December, 2021 FDA 483 ProTom International Holding Corporation - Form 483, 2021-12-14
July, 2021 FDA 483 Lymol Medical Corporation - Form 483, 2021-07-29
September, 2017 EIR Terumo Cardiovascular Systems Corp - EIR, 2017-09-25
August, 2023 FDA 483 Zyno Medical LLC - Form 483, 2023-09-06
July, 2018 FDA 483 Cynosure, Inc. - Form 483, 2018-07-27
January, 2018 FDA 483 Bandwagon, Inc. - Form 483, 2018-01-26
March, 2018 FDA 483 Biosensics LLC - Form 483, 2018-03-16
March, 2020 FDA 483 Mevion Medical Systems, Inc. - Form 483, 2020-03-05
January, 2020 FDA 483 NeuroLogica Corporation - Form 483, 2020-01-14
April, 2024 FDA 483 Spectra Medical Devices, LLC - Form 483, 2024-04-25
June, 2024 FDA 483 Medtronic Navigation, Inc.-Boxborough - Form 483, 2024-06-11
March, 2024 FDA 483 Globus Medical, Inc. - Form 483, 2024-03-28
February, 2024 FDA 483 Karl Storz Endoscopy America Inc - Form 483, 2024-02-15
August, 2024 FDA 483 Philips Ultrasound, Inc. - Form 483, 2024-08-08
November, 2024 FDA 483 Philips North America LLC - Form 483, 2024-11-06
October, 2024 FDA 483 Mevion Medical Systems, Inc. - Form 483, 2024-10-09

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more